FDA inspection
Centrient Pharmaceuticals Spain S.A.: FDA inspection ending May 30, 2024
FDA inspection 1285906 · Voluntary Action Indicated (VAI) · Santa Perpetua De Mogoda
Key facts
| Inspection ID | 1285906 |
|---|---|
| Firm | Centrient Pharmaceuticals Spain S.A. |
| FEI number | 3003754230 |
| Address | C Ripolles, 2, Poligono Urvasa |
| City | Santa Perpetua De Mogoda |
| Country | Spain |
| Fiscal year | 2024 |
| Inspection end date | May 30, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data